SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 18 filers reported holding SEATTLE GENETICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,054,000 | -1.6% | 41,024 | +69.1% | 0.01% | -14.3% |
Q2 2020 | $4,122,000 | +122.2% | 24,260 | +50.9% | 0.01% | -12.5% |
Q1 2020 | $1,855,000 | +69.9% | 16,073 | +68.2% | 0.02% | +128.6% |
Q4 2019 | $1,092,000 | +80.2% | 9,554 | +34.6% | 0.01% | +75.0% |
Q3 2019 | $606,000 | +21.4% | 7,100 | -1.7% | 0.00% | 0.0% |
Q2 2019 | $499,000 | -5.7% | 7,220 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $529,000 | +29.3% | 7,220 | 0.0% | 0.00% | -20.0% |
Q4 2018 | $409,000 | -52.6% | 7,220 | -35.5% | 0.01% | -28.6% |
Q3 2018 | $863,000 | +16.2% | 11,188 | 0.0% | 0.01% | +16.7% |
Q2 2018 | $743,000 | +26.8% | 11,188 | 0.0% | 0.01% | +20.0% |
Q1 2018 | $586,000 | -0.2% | 11,188 | +2.0% | 0.01% | 0.0% |
Q4 2017 | $587,000 | -1.7% | 10,968 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $597,000 | -30.3% | 10,968 | -33.8% | 0.01% | -37.5% |
Q2 2017 | $856,000 | -80.6% | 16,558 | -76.4% | 0.01% | -80.0% |
Q1 2017 | $4,403,000 | +1126.5% | 70,057 | +929.0% | 0.04% | +900.0% |
Q4 2016 | $359,000 | – | 6,808 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |